Literature DB >> 8289121

Surface recovery and stripping methods to quantify percutaneous absorption of caffeine in humans.

O Chambin-Remoussenard1, P Treffel, Y Bechtel, P Agache.   

Abstract

The percutaneous absorption of caffeine from two vehicles, an emulsion and an acetone solution, was quantified by in vivo techniques in humans. A surface recovery technique over a 6-h application and a stripping method after a 30-min application were performed on the volar aspect of the forearm on 12 volunteers. Caffeine was assessed by HPLC. Two phases were distinguished in the percutaneous absorption of caffeine: a higher filling up of the stratum corneum with the oil-in-water emulsion than with the acetone solution, which was then followed by a steady-state flux corresponding to the penetration in the living tissues. The permeability constants (Kp) with emulsion and acetone were 1.59 x 10(-4) and 9.53 x 10(-8) cm/h, respectively. The stripping method showed concentrations of caffeine in stratum corneum that were five times higher with emulsion (212 ng/cm2) than with acetone (37 ng/cm2). With acetone as a vehicle, approximately 40% of caffeine of the cornfield layer was found around the treated area. This sizeable lateral spread within the stratum corneum was not observed with the emulsion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8289121     DOI: 10.1002/jps.2600821107

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Infrared spectroscopic imaging tracks lateral distribution in human stratum corneum.

Authors:  Qihong Zhang; Peter Saad; Guangru Mao; Russel M Walters; Mary Catherine Mack Correa; Richard Mendelsohn; Carol R Flach
Journal:  Pharm Res       Date:  2014-05-03       Impact factor: 4.200

2.  In vivo determination of the diclofenac skin reservoir: comparison between passive, occlusive, and iontophoretic application.

Authors:  Ron Clijsen; Jean Pierre Baeyens; André Odilon Barel; Peter Clarys
Journal:  Drug Des Devel Ther       Date:  2015-02-13       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.